Prioritized Examination of COVID-19 Related Trademarks
Posted on Jun 16, 2020 in News
The United States Patent and Trademark Office (USPTO) announced that it will accept petitions filed on or after […]
Read MoreTen Caesar Rivise, PC Lawyers are 2020 SUPER LAWYERS
Posted on Jun 11, 2020 in Firm News
Ten Caesar Rivise attorneys have been selected to the 2020 Pennsylvania Super Lawyers list. Each year, no more […]
Read MoreExpedited Examination of COVID-19 Related Patent Applications
Posted on May 8, 2020 in News
On May 8, 2020, the United States Patent and Trademark Office (USPTO) announced that it will begin granting […]
Read MorePatenting and Licensing of COVID-19-Related Inventions
Posted on May 5, 2020 in News
The United States Patent and Trademark Office today issued a press release unveiling a new web-based intellectual property […]
Read MoreHijacked Amazon.com Product Listings and Trademark Registration
Posted on Mar 17, 2020 in Articles
An article posted on March 13, 2020 by Vox illustrates the importance of registering trademarks in goods sold […]
Read MoreCR @ 2019 BIO International Convention
Posted on Jun 7, 2019 in Firm News
Joe Murphy (pictured), David Tener, manned the Caesar Rivise booth at the BIO International Convention in Philadelphia June 3-6, […]
Read MoreCaesar Rivise @ #BIO2019
Posted on May 30, 2019 in Firm News
Caesar Rivise attorney David Tener, will be attending the BIO International Convention in Philadelphia on June 3-6, 2019. […]
Read MoreThe Deepest Bench of the Best Lawyers
Posted on May 2, 2019 in Firm News
Caesar Rivise isn’t the largest law firm in Pennsylvania, but it does have more attorneys recognized in The […]
Read MoreCaesar Rivise PC Receives Tier 1 Ranking in 2019 from Best Lawyers – U.S. News & World Report
Posted on Nov 1, 2018 in News
We are pleased to announce that Best Lawyers – U.S. News & World Report has placed Caesar Rivise […]
Read MoreU.S. Supreme Court Opinion Should Speed the Launch of Biosimilars
Posted on Jun 14, 2017 in Blog
The U.S. Supreme Court on June 12, 2017 issued an opinion in the consolidated cases of Sandoz Inc. v. Amgen Inc. et al. and Amgen Inc. et al. v. Sandoz Inc. which should result in more competition in the biologicals market more quickly.
Read More